Exploratory Pharmacodynamic Study of Tenofovir-Based Products

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
HIV
Interventions
DRUG

Tenofovir intravaginal ring

The participant will wear the intravaginal ring consecutively for 14 days and nights. Following study product use and at study visit 4, blood and genital tract samples will be taken (to include cervico-vaginal fluid and tissue)

DRUG

Truvada

The participant will take the tablet for 14 days. taking one tablet each morning. Following study product use and at study visit 4, blood and genital tract samples will be taken (to include cervico-vaginal fluid and tissue)

Trial Locations (1)

23507

Eastern Virginia Medical School, Norfolk

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Eastern Virginia Medical School

OTHER

collaborator

University of North Carolina

OTHER

collaborator

Agility Clinical, Inc.

INDUSTRY

lead

CONRAD

OTHER